Natarajan Sethuraman
Chief Tech/Sci/R&D Officer chez ENTRADA THERAPEUTICS, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Natarajan Sethuraman is currently the Chief Scientific Officer at Entrada Therapeutics, Inc. Previously, he worked at Merck & Co., Inc. as the Executive Director & Head-GlycoFi Site from 2012 to 2016.
He also worked as a Senior Scientist at Medical Enzymes AG.
Dr. Sethuraman received his graduate and doctorate degrees from the Indian Agricultural Research Institute and his undergraduate degree from Tamilnadu Agricultural University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,62% | 05/03/2024 | 209 032 ( 0,62% ) | 3 M $ | 31/03/2024 |
Postes actifs de Natarajan Sethuraman
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
Anciens postes connus de Natarajan Sethuraman
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Director/Board Member | 01/07/2016 |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - |
Formation de Natarajan Sethuraman
| Indian Agricultural Research Institute | Doctorate Degree |
| Tamilnadu Agricultural University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
| Entrada Therapeutics, Inc. |
